Infection of the central nervous system by Epstein-Barr virus: clinical manifestations and prognosis
The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid. We reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal flu...
Saved in:
Published in: | Revista de neurologiá Vol. 74; no. 2; p. 48 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | Spanish |
Published: |
Spain
16-01-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid.
We reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal fluid, without lymphoproliferative disease, during 2004 to 2020.
We identified 27 patients, 22 (81.5%) were men, and median age was 54 years. Twenty-three (82.1%) patients were immunosuppressed, 16 HIV-positive. In 15 (55.6%) patients coinfection with another microorganism was diagnosed and in 12 (44.4%) patients it was detected as the only pathogen. Of the 12 patients, three (25%) was immunocompetent patients, one had Guillain Barre syndrome (GBS), another had disseminated multiphasic encephalitis, and another had lymphocytic meningitis; 9 (75%) immunosuppressed, 7 HIV-positive, 4 had encephalitis that resolved without sequelae and 4 had encephalopathy, two HIH-positive had moderate cognitive impairment as a sequela.
In our study, EBV produced encephalitis, meningitis, polyradiculomyelitis and GBS, mainly in immunosuppressed patients. In more than half of the cases, it is associated with other pathogens where the role of EBV is unclear. In immunocompetent patient, the infection can be serious and leave sequelae and in HIV-positive patients with encephalopatic involvement without encephalitis, the neurological damage could be greater, so we consider it of interest to carry out studies to evaluate the prognosis as well as the role of antivirals in the evolucion of these clinical pictures. |
---|---|
AbstractList | The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid.
We reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal fluid, without lymphoproliferative disease, during 2004 to 2020.
We identified 27 patients, 22 (81.5%) were men, and median age was 54 years. Twenty-three (82.1%) patients were immunosuppressed, 16 HIV-positive. In 15 (55.6%) patients coinfection with another microorganism was diagnosed and in 12 (44.4%) patients it was detected as the only pathogen. Of the 12 patients, three (25%) was immunocompetent patients, one had Guillain Barre syndrome (GBS), another had disseminated multiphasic encephalitis, and another had lymphocytic meningitis; 9 (75%) immunosuppressed, 7 HIV-positive, 4 had encephalitis that resolved without sequelae and 4 had encephalopathy, two HIH-positive had moderate cognitive impairment as a sequela.
In our study, EBV produced encephalitis, meningitis, polyradiculomyelitis and GBS, mainly in immunosuppressed patients. In more than half of the cases, it is associated with other pathogens where the role of EBV is unclear. In immunocompetent patient, the infection can be serious and leave sequelae and in HIV-positive patients with encephalopatic involvement without encephalitis, the neurological damage could be greater, so we consider it of interest to carry out studies to evaluate the prognosis as well as the role of antivirals in the evolucion of these clinical pictures. The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid.INTRODUCTIONThe role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid.We reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal fluid, without lymphoproliferative disease, during 2004 to 2020.PATIENTS AND METHODSWe reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal fluid, without lymphoproliferative disease, during 2004 to 2020.We identified 27 patients, 22 (81.5%) were men, and median age was 54 years. Twenty-three (82.1%) patients were immunosuppressed, 16 HIV-positive. In 15 (55.6%) patients coinfection with another microorganism was diagnosed and in 12 (44.4%) patients it was detected as the only pathogen. Of the 12 patients, three (25%) was immunocompetent patients, one had Guillain Barre syndrome (GBS), another had disseminated multiphasic encephalitis, and another had lymphocytic meningitis; 9 (75%) immunosuppressed, 7 HIV-positive, 4 had encephalitis that resolved without sequelae and 4 had encephalopathy, two HIH-positive had moderate cognitive impairment as a sequela.RESULTSWe identified 27 patients, 22 (81.5%) were men, and median age was 54 years. Twenty-three (82.1%) patients were immunosuppressed, 16 HIV-positive. In 15 (55.6%) patients coinfection with another microorganism was diagnosed and in 12 (44.4%) patients it was detected as the only pathogen. Of the 12 patients, three (25%) was immunocompetent patients, one had Guillain Barre syndrome (GBS), another had disseminated multiphasic encephalitis, and another had lymphocytic meningitis; 9 (75%) immunosuppressed, 7 HIV-positive, 4 had encephalitis that resolved without sequelae and 4 had encephalopathy, two HIH-positive had moderate cognitive impairment as a sequela.In our study, EBV produced encephalitis, meningitis, polyradiculomyelitis and GBS, mainly in immunosuppressed patients. In more than half of the cases, it is associated with other pathogens where the role of EBV is unclear. In immunocompetent patient, the infection can be serious and leave sequelae and in HIV-positive patients with encephalopatic involvement without encephalitis, the neurological damage could be greater, so we consider it of interest to carry out studies to evaluate the prognosis as well as the role of antivirals in the evolucion of these clinical pictures.CONCLUSIONSIn our study, EBV produced encephalitis, meningitis, polyradiculomyelitis and GBS, mainly in immunosuppressed patients. In more than half of the cases, it is associated with other pathogens where the role of EBV is unclear. In immunocompetent patient, the infection can be serious and leave sequelae and in HIV-positive patients with encephalopatic involvement without encephalitis, the neurological damage could be greater, so we consider it of interest to carry out studies to evaluate the prognosis as well as the role of antivirals in the evolucion of these clinical pictures. |
Author | Lagarejos-González, E Redondo-Betancor, G Díaz-Nicolás, S Pena-López, M J Chamizo-López, F J Gilarranz-Luengo, R |
Author_xml | – sequence: 1 givenname: E surname: Lagarejos-González fullname: Lagarejos-González, E organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España – sequence: 2 givenname: R surname: Gilarranz-Luengo fullname: Gilarranz-Luengo, R organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España – sequence: 3 givenname: F J surname: Chamizo-López fullname: Chamizo-López, F J organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España – sequence: 4 givenname: S surname: Díaz-Nicolás fullname: Díaz-Nicolás, S organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España – sequence: 5 givenname: G surname: Redondo-Betancor fullname: Redondo-Betancor, G organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España – sequence: 6 givenname: M J surname: Pena-López fullname: Pena-López, M J organization: Hospital Universitario de Gran Canaria Dr. Negrín, 35020 Las Palmas de Gran Canaria, España |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35014019$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkL1PwzAUxC1UREthZ0IeWVLs-Ctmg6pApUosMEeO8wxGiRPspFL_e4IoEtO74ae7e3eOZqELgNAVJSvGRFHcxrBSnOSrnOSUE3mCFlQomUmhitk_PUfnKX0SwhnX5AzNmSATTvUC1dvgwA6-C7hzePgAbCEM0TQ4QNx3Y8LpkAZocXXAm35SPmQPJka893FMd9g2Png74a0J3kEazI9XwibUuI_de-iSTxfo1JkmweXxLtHb4-Z1_ZztXp626_td1lNOh8zVeVU7YZVWhDCn8wKULBR3wCrGhatVTXVFQWttibDSGs0kaEe0BJI7w5bo5td3Sv4apzJl65OFpjEBplfKXNJCEy4Fn9DrIzpWLdRlH31r4qH8W4Z9A382aS8 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.33588/rn.7402.2021406 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Infección del sistema nervioso central por el virus de Epstein-Barr: manifestaciones clínicas y pronóstico |
EISSN | 1576-6578 |
ExternalDocumentID | 35014019 |
Genre | Journal Article |
GroupedDBID | 123 2WC 53G ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK ECM EIF F5P NPM OK1 PGMZT RPM Z7D ~OR 7X8 |
ID | FETCH-LOGICAL-p141t-fd2bdf5c797003f928e76874fe3b345fd7d19b1e999c05c6ca936e9f096e02fa3 |
ISSN | 1576-6578 |
IngestDate | Sat Oct 26 16:49:20 EDT 2024 Sat Nov 02 11:55:39 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | Spanish |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p141t-fd2bdf5c797003f928e76874fe3b345fd7d19b1e999c05c6ca936e9f096e02fa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35014019 |
PQID | 2618904654 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2618904654 pubmed_primary_35014019 |
PublicationCentury | 2000 |
PublicationDate | 2022-01-16 |
PublicationDateYYYYMMDD | 2022-01-16 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | Spain |
PublicationPlace_xml | – name: Spain |
PublicationTitle | Revista de neurologiá |
PublicationTitleAlternate | Rev Neurol |
PublicationYear | 2022 |
SSID | ssj0043490 |
Score | 2.3009365 |
Snippet | The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 48 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Central Nervous System Viral Diseases - diagnosis Epstein-Barr Virus Infections - diagnosis Female Humans Male Middle Aged Prognosis Retrospective Studies Young Adult |
Title | Infection of the central nervous system by Epstein-Barr virus: clinical manifestations and prognosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35014019 https://www.proquest.com/docview/2618904654 |
Volume | 74 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe6ceGCQHyNLxmJW2VIYueLG1vTDSkaBzppt8iJHegESZW0SPSv5z3bSbtpSOPAJarc2mnzfn1-P78vQt7xKI79UmKPMA4ERXDOZMgj7JrKS2PgJpjvfPY1Pr9MZpnIJpOhYddu7L9KGsZA1pg5-w_SHheFAXgNMocrSB2ud5L7Zxdd1Qzefxd-OW1AK2C8q63djGZntuqx1yU7ll03_bXsNiY8bsyVxMoYte7XLljOVhRoMTBv2e_btOhegE9NlZ6a6pioTY3_fZRmLrGZ7lXbs9O22dr3ftij6zER4nQJHBs2zi3LN7r51l4LZjz5Ln8uty3Lce4xX9m5851Pa2YWncktM9C2t-h3R7vuXCPAABFm0y4HVRxHGJhjtbO-Zczpb9vlx-E02FPGtoTnzT2C8zDBxIeueR8Lk4sXAMm8pRz3-ZdifpHnxSK7XByQewFoMj4cB9mtXnBhDvHGr2X94OYOH26s_3cGYyyZxUPywFEQ-sli5xGZ6P4xUSNuaFtTwA11uKEON9Tihpa_6T5uqMHNRzqghl5HDQXU0BE1T8jFPFucnDHXgYOtfOGvWa2CUtVhFacxaP86DRIN_95Y1JqXXIS1ipWflr4GllF5YRVVMuWRTmvgxdoLasmfksOmbfRzQpVCYzWNSgUMtvKk5FyLREXSi2QCpOmIvB2eTwEaDt1WstHw8wrg-EnqYd2_I_LMPrhiZUuxFMYtDizlxR1mvyT3dzh7RQ7X3Ua_Jge92rwxUv0DMFF2eA |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Infection+of+the+central+nervous+system+by+Epstein-Barr+virus%3A+clinical+manifestations+and+prognosis&rft.jtitle=Revista+de+neurologi%C3%A1&rft.au=Lagarejos-Gonz%C3%A1lez%2C+E&rft.au=Gilarranz-Luengo%2C+R&rft.au=Chamizo-L%C3%B3pez%2C+F+J&rft.au=D%C3%ADaz-Nicol%C3%A1s%2C+S&rft.date=2022-01-16&rft.issn=1576-6578&rft.eissn=1576-6578&rft.volume=74&rft.issue=2&rft.spage=48&rft_id=info:doi/10.33588%2Frn.7402.2021406&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1576-6578&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1576-6578&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1576-6578&client=summon |